Eli Lilly and Company

Eli Lilly is a leading pharmaceutical company that develops diabetes, oncology, immunology, and neuroscience medicines. Its top-selling drugs include Trulicity (treatment of type 2 diabetes in adults and pediatric patients 10 years of age and older, and reducing the risk of adverse cardiovascular events in adult patients with type 2 diabetes and cardiovascular risk factors); Mounjaro (treatment of adults with type 2 diabetes in combination with diet and exercise to improve glycemic control); Verzenio (treatment of breast cancer and early breast cancer); and Taltz (for the treatment of adults and pediatric patients aged 6 years or older with moderate-to-severe plaque psoriasis, adults with active psoriatic arthritis, adults with ankylosing spondylitis, and adults with active non-radiographic axial spondyloarthritis). The company generates most of its revenue in the US.

Pharmaceutical and Medicine Manufacturing; Chemical Manufacturing; Manufacturing

Pharmaceutical Preparations; Chemicals and Allied Products; Manufacturing

$34120M